China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited by American Association of Blood Banks

HONG KONG, Oct. 30, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company's Guangdong subsidiary, Guangdong Cord Blood Bank, was accredited by American Association of Blood Banks (AABB) in October 2015.

"AABB is the world's most respected standard setting organization in cord blood banking. Facilities undergo a stringent accreditation process that includes auditing activities from client education and obtainment of cord blood, processing, testing and storage," said Ms. Ting Zheng, Chief Executive Officer of CCBC, "We are proud that Guangdong Cord Blood Bank has become AABB-accredited. CCBC will continue to maintain the highest standards of quality and strive to secure optimal healthcare alternatives for our clients' children."

About American Association of Blood Banks

Since 1957, AABB has been developing standards for blood banks and transfusion services. From the 1980s to the present standards for Cellular Therapies, Patient Blood Management and other aspects have been added to the standards library. The corresponding accreditation programs strive to improve the quality and safety of the activities covered by the standards. By assessing the quality and operational systems in place within a facility, the program strives to improve the safety of collecting, processing, testing, distributing and administering blood and blood products. For more information on AABB standard, please visit: www.aabb.org.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: [email protected]

ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: [email protected]

SOURCE China Cord Blood Corporation

Related Links

http://www.chinacordbloodcorp.com